Coleman Mark (CIK 1658379) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-10). Recent activity: Buy AXSM (1,429 shares), Sell AXSM (643 shares), Sell AXSM (6,000 shares), Sell AXSM (6,000 shares), Sell AXSM (5,537 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-10 | Axsome Therapeutics, Inc. (AXSM) | Director | Buy | 1,429 | $0 |
| 2026-06-10 | Axsome Therapeutics, Inc. (AXSM) | Director | Sell | 643 | $160,107 |
| 2026-06-02 | Axsome Therapeutics, Inc. (AXSM) | Director | Sell | 6,000 | $1.4M |
| 2026-06-02 | Axsome Therapeutics, Inc. (AXSM) | Director | Sell | 6,000 | $1.4M |
| 2026-06-02 | Axsome Therapeutics, Inc. (AXSM) | Director | Sell | 5,537 | $1.2M |
| 2026-02-27 | Axsome Therapeutics, Inc. (AXSM) | Director | Sell | 25,000 | $4.0M |
| 2026-02-25 | Axsome Therapeutics, Inc. (AXSM) | Director | Buy | 6,250 | $30,938 |
| 2026-02-23 | Axsome Therapeutics, Inc. (AXSM) | Director | Buy | 12,485 | $61,801 |
| 2026-02-10 | Axsome Therapeutics, Inc. (AXSM) | Director | Buy | 5,193 | $41,648 |
| 2025-09-09 | Axsome Therapeutics, Inc. (AXSM) | Director | Buy | 287 | $36,535 |
| 2025-09-09 | Axsome Therapeutics, Inc. (AXSM) | Director | Buy | 800 | $101,760 |
| 2025-09-09 | Axsome Therapeutics, Inc. (AXSM) | Director | Buy | 488 | $62,171 |
| 2025-05-29 | Axsome Therapeutics, Inc. (AXSM) | Director | Sell | 3,750 | $395,512 |
| 2025-05-29 | Axsome Therapeutics, Inc. (AXSM) | Director | Sell | 3,750 | $387,862 |
| 2025-05-20 | Axsome Therapeutics, Inc. (AXSM) | Director | Sell | 3,000 | $322,470 |
Source: SEC Form 4 filings · as of 2026-06-10